Stereotaxis Inc
Company Profile
Business description
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Contact
710 North Tucker Boulevard
Suite 110
St. LouisMO63101
USAT: +1 314 678-6100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
122
Stocks News & Analysis
stocks
The lessons behind the best performing stock over the last 80 years
stocks
10 of the cheapest global companies with wide moats
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,089.90 | 7.80 | 0.10% |
| CAC 40 | 8,102.30 | 28.32 | 0.35% |
| DAX 40 | 23,308.30 | 153.73 | 0.66% |
| Dow JONES (US) | 41,488.56 | 353.07 | -0.84% |
| FTSE 100 | 8,689.55 | 9.26 | 0.11% |
| HKSE | 24,740.57 | 595.00 | 2.46% |
| NASDAQ | 17,490.94 | 317.72 | -1.78% |
| Nikkei 225 | 37,845.42 | 448.90 | 1.20% |
| NZX 50 Index | 12,076.85 | 89.29 | -0.73% |
| S&P 500 | 5,604.91 | 70.21 | -1.24% |
| S&P/ASX 200 | 7,860.40 | 6.30 | 0.08% |
| SSE Composite Index | 3,429.76 | 3.63 | 0.11% |